Phil Nader
Analyst
TD Cowen
Equibles does not estimate personal net worth.
About Phil Nader
Phil Nader is recorded as Analyst at TD Cowen. Phil Nader has spoken on 1 earnings call across 1 company, most recently for Biomarin Pharmaceutical Inc on February 23, 2026. The companies whose calls Phil Nader spoke on are classified in the Healthcare sector.
Phil Nader on recent calls
“Another question on Voxelga, but on hypochondriplasia. Can you help us frame the upcoming results? What magnitude of growth velocity increase do you think would be meaningful in hypochondriplasia patients?”
Affiliation history
-
TD Cowen
Analyst
Transcript header (unverified)
Current